Florida Cancer Specialists & Research Institute Welcomes Nathan H. Walcker as Chief Financial Officer

Fort Myers, Fla., August 5, 2019 — Florida Cancer Specialists & Research Institute (FCS) is pleased to announce the appointment of Nathan H. Walcker to the Executive Leadership Team as Chief Financial Officer. In this role, Walcker will oversee the organization’s finance and accounting operations, business planning and investments, and fiscal compliance policy and practices.

Headshot-for-Press-Release-Nate-Walcker

He brings over a decade of diverse healthcare industry experience and finance expertise to FCS, most recently serving as an integral member of Bank of America Merrill Lynch’s healthcare investment banking group, where he was responsible for advising leading healthcare companies on mergers, acquisitions, and capital structure strategies.

 

Walcker earned an MBA from Columbia Business School and a bachelor’s degree in Economics from Columbia University.

Deeply committed to community service, Walcker serves on several community boards. He previously served as a board member of Lime Connect, a nonprofit that connects high potential students and professionals with disabilities with professional development opportunities.

“We are impressed with Nathan’s energy and his passion for delivering on our mission,” said FCS CEO Brad Prechtl, MBA.  “He is well-equipped to provide the level of strategic financial guidance and leadership that will enhance our capacity and effectiveness in serving patients who are battling cancer.”

FCS President & Managing Physician Dr. Lucio N. Gordan added, “Nathan’s strong financial background and business acumen, as well as his particular focus on best practices and technology, will enable us to continuously improve both the cost and quality of patient care."

###

About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. In the past four years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.*  Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.

Founded in 1984, FCS is one of the largest medical oncology/hematology practices in the United States. With more than 230 physicians, 220 advanced practice registered nurses (APRN) and physician assistants (PA) and nearly 100 locations in our network, we are committed to providing world-class cancer care in community-based settings.

Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research and cutting-edge technologies that help targeted treatments and genomic-based treatment and immunotherapy.  These values are embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.

*Prior to approval

For More Information, Contact:
Florida Cancer Specialists & Research Institute
Shelly Glenn, Chief Marketing & Sales Officer 
SGlenn@FLCancer.com
(770) 365.6168

Michelle Robey, Marketing Director
Michelle.Robey@FLCancer.com
(813) 767.9398